In the US, Taxotere (docetaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Breast Cancer, Breast Cancer - Metastatic, Gastric Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and Solid Tumors.
Ingredient matches for Taxotere
Docetaxel is reported as an ingredient of Taxotere in the following countries:
- Bosnia & Herzegowina
- Hong Kong
- New Zealand
Docetaxel trihydrate (a derivative of Docetaxel) is reported as an ingredient of Taxotere in the following countries:
- Dominican Republic
- El Salvador
- South Africa
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.